MyMD Pharmaceuticals, Inc.

MYMD

MYMDMyMD Pharmaceuticals, Inc. US flag

NASDAQ Capital Market

1.81

USD

-0.01

- -

4.29MMarket Cap

Income Statement (USD)

API ChatGPT

	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	8	28	15	16
+ Selling, General & Admin	6	21	6	8
+ Research & Development	2	7	9	8
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-8	-28	-15	-16
- Non-Operating (Income) Loss	1	2	- -	-12
+ Interest Expense, Net	1	1	- -	- -
+ Interest Expense	1	1	- -	- -
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	1	- -	-12
Pretax Income	-9	-30	-15	-4
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-9	-30	-15	-4
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-9	-30	-15	-4
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-9	-30	-15	-4
- Preferred Dividends	- -	- -	- -	4
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-9	-30	-15	-8
EBIT	-8	-28	-15	-16
EBITDA	-8	-28	-15	-16
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	-8	-28	-15	-16
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	0.94
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	1	1	1	2
Basic EPS, GAAP	-7.66	-25.61	-11.74	-5.33
Basic EPS from Cont Ops	-7.66	-25.61	-11.74	-2.59
Diluted Weighted Avg Shares	1	1	1	2
Diluted EPS, GAAP	-7.66	-25.61	-11.74	-5.33
Diluted EPS from Cont Ops	-7.66	-25.61	-11.74	-2.59

Balance Sheet (USD)

API ChatGPT

	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Current Assets	- -	13	5	6
+ Cash, Cash Equivalents & STI	- -	12	5	5
+ Cash & Cash Equivalents	- -	1	1	3
+ ST Investments	- -	11	4	2
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	- -	1	1	1
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	1	12	12	12
+ Property, Plant & Equip, Net	1	- -	- -	- -
+ Property, Plant & Equip	1	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	2	2	2
+ LT Investments	- -	2	2	2
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	10	10	10
+ Total Intangible Assets	- -	10	10	10
+ Goodwill	- -	10	10	10
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -
Total Assets	1	25	18	18
+ Payables & Accruals	2	1	3	4
+ Accounts Payable	2	1	2	3
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	1
+ ST Debt	1	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	- -	1
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	1
Total Current Liabilities	2	1	3	5
+ LT Debt	4	- -	- -	- -
+ LT Borrowings	4	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -
Total Noncurrent Liabilities	4	- -	- -	- -
Total Liabilities	6	1	3	5
+ Preferred Equity and Hybrid Capital	- -	- -	- -	1
+ Share Capital & APIC	43	102	108	114
+ Common Stock	- -	102	- -	- -
+ Additional Paid in Capital	43	- -	108	114
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-49	-79	-94	-102
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-5	24	15	13
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-5	24	15	13
Total Liabilities & Equity	1	25	18	18
Shares Outstanding	1	1	1	2
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	1	- -	- -	- -
Net Debt	3	-1	-1	-3
Net Debt to Equity	-65.75	-2.35	-5.1	-20.99
Tangible Common Equity Ratio	-776.87	90.85	57.54	23.45
Current Ratio	0.06	12.18	1.95	1.17
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023

+ Net Income	-9	-30	-15	-4
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	4	16	1	-10
+ Stock-Based Compensation	- -	- -	1	3
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	4	16	- -	-13
+ Chg in Non-Cash Work Cap	1	-5	2	1
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-1	1	- -
+ Inc (Dec) in Accts Payable	1	-4	2	1
+ Inc (Dec) in Other	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-5	-20	-12	-13
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	2	- -	6	- -
+ Increase in Capital Stock	2	- -	6	- -
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	18	7	2
+ Dec in LT Investment	- -	18	12	15
+ Inc in LT Investment	- -	- -	-5	-13
+ Net Cash From Acq & Div	- -	1	- -	- -
+ Cash from Divestitures	- -	1	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	20	7	2
+ Dividends Paid	- -	- -	- -	-1
+ Net Cash From Debt	3	-1	- -	- -
+ Cash From Debt	3	2	- -	- -
+ Repayments of Debt	- -	-3	- -	- -
+ Other Financing Activities	- -	1	- -	15
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	5	- -	6	13
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	- -	- -	- -	2
EBITDA	-8	-28	-15	-16
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	-5	-20	-12	-13
Net Cash Paid for Acquisitions	- -	-1	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-20	-12	-17
Free Cash Flow per Basic Share	-3.77	-16.72	-9.48	-8.42
Price/Free Cash Flow	-31.69	-10.87	-3.64	-0.92
Cash Flow to Net Income	0.49	0.65	0.81	3.25
Capital Expenditures	- -	- -	- -	- -